Published in J Cereb Blood Flow Metab on November 01, 1995
Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A (1999) 1.50
Oximetry-guided reoxygenation improves neurological outcome after experimental cardiac arrest. Stroke (2006) 1.31
Reactive oxygen species and respiratory plasticity following intermittent hypoxia. Respir Physiol Neurobiol (2008) 1.27
Respiratory long-term facilitation following intermittent hypoxia requires reactive oxygen species formation. Neuroscience (2008) 1.26
Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol (2008) 1.21
Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J Cereb Blood Flow Metab (2014) 1.07
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats. J Neurochem (2010) 0.88
Cerebroprotective effect of Moringa oleifera against focal ischemic stroke induced by middle cerebral artery occlusion. Oxid Med Cell Longev (2013) 0.83
Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantification of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique. J Physiol (2013) 0.79
Impact of Ginkgo Biloba Extract EGb 761 on ischemia/reperfusion - induced oxidative stress products formation in rat forebrain. Cell Mol Neurobiol (2006) 0.79
Role of matrix metalloproteinase activity in the neurovascular protective effects of Angiotensin antagonism. Stroke Res Treat (2014) 0.78
Synergic Effect of Borneol and Ligustrazine on the Neuroprotection in Global Cerebral Ischemia/Reperfusion Injury: A Region-Specificity Study. Evid Based Complement Alternat Med (2016) 0.77
Discovery of 3-n-butyl-2,3-dihydro-1H-isoindol-1-one as a potential anti-ischemic stroke agent. Drug Des Devel Ther (2015) 0.76
Imaging of reactive oxygen species in focal ischemic mouse brain using a radical trapping tracer [(3)H]hydromethidine. EJNMMI Res (2015) 0.75
SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY. J Biol Chem (2015) 0.75
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Heparin treatment in sinus venous thrombosis. Lancet (1991) 5.02
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68
Spontaneous low frequency oscillations of cerebral hemodynamics and metabolism in human adults. Neuroimage (2000) 4.07
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Capillary perfusion of the rat brain cortex. An in vivo confocal microscopy study. Circ Res (1994) 2.65
A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology (2011) 2.57
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Vascular imprints of neuronal activity: relationships between the dynamics of cortical blood flow, oxygenation, and volume changes following sensory stimulation. Proc Natl Acad Sci U S A (1997) 2.28
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology (2000) 2.23
Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut (2009) 2.20
Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology (1998) 2.15
The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology (2005) 2.13
No evidence for early decrease in blood oxygenation in rat whisker cortex in response to functional activation. Neuroimage (2001) 2.07
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet (2001) 1.94
Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke (2003) 1.93
Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry (2009) 1.89
Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun (2004) 1.89
Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology (1998) 1.86
Postural dependency of the cerebral venous outflow. Lancet (2000) 1.81
Acute severe spinal cord dysfunction in bacterial meningitis in adults: MRI findings suggest extensive myelitis. Arch Neurol (2001) 1.79
Constraint-induced movement therapy for motor recovery in chronic stroke patients. Arch Phys Med Rehabil (1999) 1.78
Characterization of CBF response to somatosensory stimulation: model and influence of anesthetics. Am J Physiol (1993) 1.77
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (1996) 1.70
Predictors of PTSD in injured trauma survivors: a prospective study. Am J Psychiatry (1996) 1.68
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol (1984) 1.64
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke (2002) 1.62
Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection (1990) 1.61
An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics (2001) 1.61
Oxidative stress in bacterial meningitis in humans. Neurology (2002) 1.60
Simultaneous recording of cerebral blood oxygenation changes during human brain activation by magnetic resonance imaging and near-infrared spectroscopy. J Cereb Blood Flow Metab (1996) 1.57
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato. Med Microbiol Immunol (1994) 1.56
Neural correlates of the volitional regulation of the desire for food. Int J Obes (Lond) (2011) 1.55
Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J (2010) 1.55
Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol (1999) 1.53
Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: assessment with MR and transcranial Doppler sonography. AJNR Am J Neuroradiol (1998) 1.50
Prevalence of stroke and stroke symptoms: a population-based survey of 28,090 participants. Neuroepidemiology (2008) 1.50
Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest (1993) 1.50
Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis. Aliment Pharmacol Ther (1998) 1.47
Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1998) 1.46
Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). J Infect Dis (1986) 1.45
Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab (1998) 1.44
Clinical management of Lyme borreliosis. Lancet (1994) 1.44
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol (2002) 1.44
Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study. Aliment Pharmacol Ther (2014) 1.43
Endoscopic ultrasound of the colon for the differentiation of Crohn's disease and ulcerative colitis in comparison with healthy controls. Aliment Pharmacol Ther (2014) 1.43
Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry (2011) 1.43
Serological diagnosis of erythema migrans disease and related disorders. Infection (1985) 1.42
Noninvasive functional imaging of human brain using light. J Cereb Blood Flow Metab (2000) 1.41
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut (2002) 1.41
The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients. Cephalalgia (2006) 1.41
Inferior subluxation of the humeral head: the drooping shoulder. Radiology (1971) 1.39
Determining changes in NIR absorption using a layered model of the human head. Phys Med Biol (2001) 1.36
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome). J Neurol (1984) 1.34
In-vivo confocal scanning laser microscopy of the cerebral microcirculation. J Microsc (1992) 1.32
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut (2003) 1.31
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol (1997) 1.31
Physical model for the spectroscopic analysis of cortical intrinsic optical signals. Phys Med Biol (2000) 1.30
Effect of aging on stimulus-reward association learning. Neuropsychologia (2004) 1.30
Reward-based decision-making and aging. Brain Res Bull (2005) 1.29
Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience (2003) 1.29
Somatotopic organization of human secondary somatosensory cortex. Cereb Cortex (2001) 1.28
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun (2006) 1.26
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol (2000) 1.26
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension (1999) 1.26
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (1993) 1.25
Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg (2000) 1.24
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Dural sinus thrombosis: value of venous MR angiography for diagnosis and follow-up. AJR Am J Roentgenol (1994) 1.22
Bone mineralization as studied by small-angle x-ray scattering. Connect Tissue Res (1996) 1.21
Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder. Arch Gen Psychiatry (1992) 1.20
fMRI shows multiple somatotopic digit representations in human primary somatosensory cortex. Neuroreport (2000) 1.19